Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

EBMT 2021 | Curative options for X-CGD

Tayfun Güngör • 5 Mar 2021
EBMT 2021
General

Tayfun Güngör, MD, University Children’s Hospital Zurich, Zurich, Switzerland, shares a summary of his talk comparing curative options for X-linked chronic granulomatous disease (X-CGD). Dr Güngör describes the use of gene therapy for patients who do not have matched donors and compares results with those from patients who received allogeneic stem cell transplantation using alternative donors. This interview took place during the 47th Annual Meeting of the European Group for Blood and Marrow Transplantation (EBMT) 2021.

Disclosures

Dr Tayfun Güngör, MD, has participated in advisory boards for Jazz Pharmaceuticals and Novartis.

More from Tayfun Güngör

FORUM: TBI versus chemotherapy conditioning in pediatric ALL
2:45
FORUM: TBI versus chemotherapy conditioning in pediatric ALL
Tayfun Güngör • 5 Mar 2021

Related Videos

The ethical challenges of AI in hematology: patient communication, trust and regulation
3:12
The ethical challenges of AI in hematology: patient communication, trust and regulation
Adrián Mosquera Orgueira • 24 Sep 2026
The future of AI in hematology: personalized medicine, opportunities and risks
2:30
The future of AI in hematology: personalized medicine, opportunities and risks
Adrián Mosquera Orgueira • 24 Sep 2026
The multi-system impacts of CHIP and its link to subspecialties within internal medicine
5:18
The multi-system impacts of CHIP and its link to subspecialties within internal medicine
Shyam Patel • 13 Oct 2026
The scientific and clinical implications of therapy-related CHIP in oncology
2:43
The scientific and clinical implications of therapy-related CHIP in oncology
Shyam Patel • 13 Oct 2026

Choose your cookie settings

VJHemOnc uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.

Cookie Policy (opens in a new tab)
The content of VJHemOnc is intended for healthcare professionals